Home » Topics » BioWorld Science, Infection

BioWorld Science, Infection
RSS

Antifungal activity and good tolerability in phase I trial of L-743872

May 24, 1996

Abelcet approved for marketing in Portugal

May 24, 1996

Antifungal antibiotic YM-47522 isolated by Yamanouchi

May 24, 1996

L-749345 in clinical trials at Merck & Co.

May 24, 1996

AmBisome approved in India

May 17, 1996

HNK20 moves to phase III

May 17, 1996

CMV NeutraGAM development update

May 17, 1996

Interferon Sciences reacquires U.S. and Canadian marketing rights for interferon product

May 17, 1996

IDEC receives NIAID grant to develop MAbs for RSV

May 17, 1996

Nippon Shoji to collaborate on nisin development in Pacific rim countries

May 17, 1996

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...